- OpGen Announces Closing of $10 Million Public Offering07-19-2017
- OpGen Announces Pricing of $10.0 Million Public Offering07-13-2017
- OpGen Acuitas® MDRO Gene Test Approved by NY State Department of Health07-12-2017
- OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid Test06-19-2017
Rapid Antibiotic Resistance Surveillance
CONNECT WITH OpGen
We want to add you to our list and stay connected.
Please sign up for email alerts to receive the latest OpGen news.
Microbial Whole Genome Sequencing
Now Available On Demand
Esther Babady, Ph.D
Director of Clinical Microbiology Operations, Memorial Sloan Kettering Cancer Center
This webinar will review current options for rapid pathogen identification from positive blood cultures and discuss the speaker’s experience with the use of AdvanDx QuickFISH® BC kits and their impact on the laboratory workflow and patient outcomes.
Rapid Pathogen Identification